Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chi Ying F Huang
(Contributor)
Jun-Hung Lin
(Contributor)
Alexander TH Wu
(Creator)
Pi Lin Sung
(Contributor)
Mong Hong Lee
(Contributor)
Sai Ching J. Yeung
(Contributor)
Ping Chieh Chou
(Contributor)
Kuo-Chang Wen
(Creator)
Taipei Heart Institute (THI), Taipei Medical University
International Ph.D. Program for Translational Science
Graduate Institute of Biomedical Informatics
The Ph.D. Program for Translational Medicine
Taipei Medical University Shuang Ho Hospital
Department of Obstetrics and Gynecology
Dataset
Overview
Research output
(1)
Research output
Research output per year
2020
2020
2020
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2020
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. C.
, Sung, P. L.,
Wu, A. T. H.
, Chou, P. C., Lin, J. H., Huang, C. Y. F., Yeung, S. C. J. & Lee, M. H.,
Aug 21 2020
,
In:
Journal of Ovarian Research.
13
,
1
,
p. 95
95.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Ovarian Cancer
100%
Antiproliferative Activity
100%
Glycon
100%
Clinical Trial
20%
Mammalian Target of Rapamycin
20%
18
Citations (Scopus)